For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Stay out of hospital or reduce risk of heart event? Treatment decision gets more complex
+Print Archive
News
Stay out of hospital or reduce risk of heart event? Treatment decision gets more complex
Wednesday 9 June 2021, 01:40 AM

Auckland cardiologist Harvey White says there is a trade-off for patients in invasive versus conservative treatment
Researchers have found invasive or conservative treatment makes little difference to certain heart patients’ key outcomes after four years.
The stud
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
White HD, O’Brien SM, Alexander MD, et al. Comparison of days alive out of hospital with invasive vs conservative management, a prespecified analysis of the ISCHEMIA trial. JAMA Cardiol 2021 May 3; e211651.